Header cover image

Chinese Pharmaceuticals & Biotech Your first investment

Results

8

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

8 companies

Yunnan Baiyao GroupLtd

Market Cap: CN¥88.3b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥50.00

7D

1.0%

1Y

-13.5%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥74.7b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

600436

CN¥126.14

7D

-2.0%

1Y

-40.1%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥39.3b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥24.11

7D

-1.6%

1Y

-21.7%

Beijing Tongrentang

Market Cap: CN¥32.6b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥24.25

7D

0.3%

1Y

-34.8%

Apeloa PharmaceuticalLtd

Market Cap: CN¥22.2b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥20.87

7D

-6.8%

1Y

26.9%

Tasly Pharmaceutical Group

Market Cap: CN¥22.1b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥14.75

7D

-4.2%

1Y

-14.3%

Livzon Pharmaceutical Group

Market Cap: CN¥20.9b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥25.97

7D

-12.6%

1Y

-37.8%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥15.6b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

600867

CN¥8.10

7D

-3.1%

1Y

-7.0%